Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
888
-
Total shares
-
38.4M
-
Shares change
-
+26.6K
-
Total reported value, excl. options
-
$5.28B
-
Value change
-
+$1.49M
-
Put/Call ratio
-
4.23
-
Number of buys
-
261
-
Number of sells
-
-385
-
Price
-
$137.26
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2024
filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q2 2024.
ISHARES TR - ISHARES BIOTECH (IBB) has 888 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.4M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (7.52M shares), GOLDMAN SACHS GROUP INC (3.15M shares), CITIGROUP INC (3.09M shares), MORGAN STANLEY (2.72M shares), JPMORGAN CHASE & CO (2.01M shares), BNP PARIBAS FINANCIAL MARKETS (1.84M shares), Royal Bank of Canada (1.28M shares), JANE STREET GROUP, LLC (984K shares), UBS Group AG (906K shares), and COMMERCE BANK (730K shares).
This table shows the top 888 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.